Mantia, C., Hanna, G. J., Loriot, Y., Vu, P., Tosi, D., Ciuleanu, T., Tripathi, A., Munster, P. N., Bhatia, A. K., Shih, L., Zivi, A., Chin, I. S., Lostes-Bardaji, M. J., Rolland, F., Barrera, I., Preugschat, K., Grant, P. M., Hodgson, I., Perez, C. A., Rosenberg, A. J. (2026). A phase 1/2 study of the next-generation nectin-4–targeting antibody-drug conjugate CRB-701 (SYS6002) in patients with recurrent or metastatic head and neck squamous cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6062